Global Lifestyle Drugs Market Research Report 2021

1 Lifestyle Drugs Market Overview

• 1.1 Product Overview and Scope of Lifestyle Drugs
• 1.2 Lifestyle Drugs Segment by Therapeutic Type
  • 1.2.1 Global Lifestyle Drugs Sales Growth Rate Comparison by Therapeutic Type (2021-2027)
  • 1.2.2 Depression
  • 1.2.3 Dermatology
  • 1.2.4 Sexual Dysfunction
  • 1.2.5 Obesity
  • 1.2.6 Others
• 1.3 Lifestyle Drugs Segment by Sales Channel
  • 1.3.1 Lifestyle Drugs Sales Comparison by Sales Channel: (2021-2027)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Lifestyle Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Lifestyle Drugs Revenue 2016-2027
  • 1.4.2 Global Lifestyle Drugs Sales 2016-2027
  • 1.4.3 Lifestyle Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Lifestyle Drugs Market Competition by Manufacturers

• 2.1 Global Lifestyle Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Lifestyle Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Lifestyle Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Lifestyle Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Lifestyle Drugs Market Competitive Situation and Trends
  • 2.5.1 Lifestyle Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Lifestyle Drugs Players Market Share by Revenue
  • 2.5.3 Global Lifestyle Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lifestyle Drugs Retrospective Market Scenario by Region

• 3.1 Global Lifestyle Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Lifestyle Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Lifestyle Drugs Market Facts & Figures by Country
  • 3.3.1 North America Lifestyle Drugs Sales by Country
  • 3.3.2 North America Lifestyle Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Lifestyle Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Lifestyle Drugs Sales by Country
  • 3.4.2 Europe Lifestyle Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Lifestyle Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Lifestyle Drugs Sales by Region
  • 3.5.2 Asia Pacific Lifestyle Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Lifestyle Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Lifestyle Drugs Sales by Country
  • 3.6.2 Latin America Lifestyle Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Lifestyle Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Lifestyle Drugs Sales by Country
  • 3.7.2 Middle East and Africa Lifestyle Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Lifestyle Drugs Historic Market Analysis by Type

• 4.1 Global Lifestyle Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Lifestyle Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Lifestyle Drugs Price by Type (2016-2021)

5 Global Lifestyle Drugs Historic Market Analysis by Sales Channel

• 5.1 Global Lifestyle Drugs Sales Market Share by Sales Channel (2016-2021)
• 5.2 Global Lifestyle Drugs Revenue Market Share by Sales Channel (2016-2021)
• 5.3 Global Lifestyle Drugs Price by Sales Channel (2016-2021)

6 Key Companies Profiled

• 6.1 Allergan
  • 6.1.1 Allergan Corporation Information
  • 6.1.2 Allergan Description and Business Overview
  • 6.1.3 Allergan Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Allergan Product Portfolio
  • 6.1.5 Allergan Recent Developments/Updates
• 6.2 Eli Lilly
  • 6.2.1 Eli Lilly Corporation Information
  • 6.2.2 Eli Lilly Description and Business Overview
  • 6.2.3 Eli Lilly Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Eli Lilly Product Portfolio
  • 6.2.5 Eli Lilly Recent Developments/Updates
• 6.3 Pfizer
  • 6.3.1 Pfizer Corporation Information
  • 6.3.2 Pfizer Description and Business Overview
  • 6.3.3 Pfizer Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Pfizer Product Portfolio
  • 6.3.5 Pfizer Recent Developments/Updates
• 6.4 AstraZeneca
  • 6.4.1 AstraZeneca Corporation Information
  • 6.4.2 AstraZeneca Description and Business Overview
  • 6.4.3 AstraZeneca Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 AstraZeneca Product Portfolio
  • 6.4.5 AstraZeneca Recent Developments/Updates
• 6.5 Teva
  • 6.5.1 Teva Corporation Information
  • 6.5.2 Teva Description and Business Overview
  • 6.5.3 Teva Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Teva Product Portfolio
  • 6.5.5 Teva Recent Developments/Updates
• 6.6 Sun Pharmacetuicals
  • 6.6.1 Sun Pharmacetuicals Corporation Information
  • 6.6.2 Sun Pharmacetuicals Description and Business Overview
  • 6.6.3 Sun Pharmacetuicals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Sun Pharmacetuicals Product Portfolio
  • 6.6.5 Sun Pharmacetuicals Recent Developments/Updates
• 6.7 Merck
  • 6.6.1 Merck Corporation Information
  • 6.6.2 Merck Description and Business Overview
  • 6.6.3 Merck Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck Product Portfolio
  • 6.7.5 Merck Recent Developments/Updates
• 6.8 Forendo Pharma
  • 6.8.1 Forendo Pharma Corporation Information
  • 6.8.2 Forendo Pharma Description and Business Overview
  • 6.8.3 Forendo Pharma Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Forendo Pharma Product Portfolio
  • 6.8.5 Forendo Pharma Recent Developments/Updates
• 6.9 Avolynt
  • 6.9.1 Avolynt Corporation Information
  • 6.9.2 Avolynt Description and Business Overview
  • 6.9.3 Avolynt Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Avolynt Product Portfolio
  • 6.9.5 Avolynt Recent Developments/Updates
• 6.10 Alkermes
  • 6.10.1 Alkermes Corporation Information
  • 6.10.2 Alkermes Description and Business Overview
  • 6.10.3 Alkermes Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Alkermes Product Portfolio
  • 6.10.5 Alkermes Recent Developments/Updates
• 6.11 Dong-A ST
  • 6.11.1 Dong-A ST Corporation Information
  • 6.11.2 Dong-A ST Lifestyle Drugs Description and Business Overview
  • 6.11.3 Dong-A ST Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Dong-A ST Product Portfolio
  • 6.11.5 Dong-A ST Recent Developments/Updates
• 6.12 Dermira
  • 6.12.1 Dermira Corporation Information
  • 6.12.2 Dermira Lifestyle Drugs Description and Business Overview
  • 6.12.3 Dermira Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Dermira Product Portfolio
  • 6.12.5 Dermira Recent Developments/Updates
• 6.13 Avanir Pharmaceuticals
  • 6.13.1 Avanir Pharmaceuticals Corporation Information
  • 6.13.2 Avanir Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.13.3 Avanir Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Avanir Pharmaceuticals Product Portfolio
  • 6.13.5 Avanir Pharmaceuticals Recent Developments/Updates
• 6.14 Menlo Therapeutics
  • 6.14.1 Menlo Therapeutics Corporation Information
  • 6.14.2 Menlo Therapeutics Lifestyle Drugs Description and Business Overview
  • 6.14.3 Menlo Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Menlo Therapeutics Product Portfolio
  • 6.14.5 Menlo Therapeutics Recent Developments/Updates
• 6.15 Galderma
  • 6.15.1 Galderma Corporation Information
  • 6.15.2 Galderma Lifestyle Drugs Description and Business Overview
  • 6.15.3 Galderma Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Galderma Product Portfolio
  • 6.15.5 Galderma Recent Developments/Updates
• 6.16 Cerecor
  • 6.16.1 Cerecor Corporation Information
  • 6.16.2 Cerecor Lifestyle Drugs Description and Business Overview
  • 6.16.3 Cerecor Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Cerecor Product Portfolio
  • 6.16.5 Cerecor Recent Developments/Updates
• 6.17 Corcept Therapeutics
  • 6.17.1 Corcept Therapeutics Corporation Information
  • 6.17.2 Corcept Therapeutics Lifestyle Drugs Description and Business Overview
  • 6.17.3 Corcept Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Corcept Therapeutics Product Portfolio
  • 6.17.5 Corcept Therapeutics Recent Developments/Updates
• 6.18 Anterios
  • 6.18.1 Anterios Corporation Information
  • 6.18.2 Anterios Lifestyle Drugs Description and Business Overview
  • 6.18.3 Anterios Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Anterios Product Portfolio
  • 6.18.5 Anterios Recent Developments/Updates
• 6.19 Euthymics Bioscience
  • 6.19.1 Euthymics Bioscience Corporation Information
  • 6.19.2 Euthymics Bioscience Lifestyle Drugs Description and Business Overview
  • 6.19.3 Euthymics Bioscience Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Euthymics Bioscience Product Portfolio
  • 6.19.5 Euthymics Bioscience Recent Developments/Updates
• 6.20 Cosmo Pharmaceuticals
  • 6.20.1 Cosmo Pharmaceuticals Corporation Information
  • 6.20.2 Cosmo Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.20.3 Cosmo Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Cosmo Pharmaceuticals Product Portfolio
  • 6.20.5 Cosmo Pharmaceuticals Recent Developments/Updates
• 6.21 AndroScience
  • 6.21.1 AndroScience Corporation Information
  • 6.21.2 AndroScience Lifestyle Drugs Description and Business Overview
  • 6.21.3 AndroScience Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 AndroScience Product Portfolio
  • 6.21.5 AndroScience Recent Developments/Updates
• 6.22 Acerus Pharmaceuticals
  • 6.22.1 Acerus Pharmaceuticals Corporation Information
  • 6.22.2 Acerus Pharmaceuticals Lifestyle Drugs Description and Business Overview
  • 6.22.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Acerus Pharmaceuticals Product Portfolio
  • 6.22.5 Acerus Pharmaceuticals Recent Developments/Updates
• 6.23 Celtaxsys
  • 6.23.1 Celtaxsys Corporation Information
  • 6.23.2 Celtaxsys Lifestyle Drugs Description and Business Overview
  • 6.23.3 Celtaxsys Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.23.4 Celtaxsys Product Portfolio
  • 6.23.5 Celtaxsys Recent Developments/Updates
• 6.24 Futura Medical Developments
  • 6.24.1 Futura Medical Developments Corporation Information
  • 6.24.2 Futura Medical Developments Lifestyle Drugs Description and Business Overview
  • 6.24.3 Futura Medical Developments Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.24.4 Futura Medical Developments Product Portfolio
  • 6.24.5 Futura Medical Developments Recent Developments/Updates
• 6.25 Follicum
  • 6.25.1 Follicum Corporation Information
  • 6.25.2 Follicum Lifestyle Drugs Description and Business Overview
  • 6.25.3 Follicum Lifestyle Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.25.4 Follicum Product Portfolio
  • 6.25.5 Follicum Recent Developments/Updates

7 Lifestyle Drugs Manufacturing Cost Analysis

• 7.1 Lifestyle Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Lifestyle Drugs
• 7.4 Lifestyle Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Lifestyle Drugs Distributors List
• 8.3 Lifestyle Drugs Customers

9 Lifestyle Drugs Market Dynamics

• 9.1 Lifestyle Drugs Industry Trends
• 9.2 Lifestyle Drugs Growth Drivers
• 9.3 Lifestyle Drugs Market Challenges
• 9.4 Lifestyle Drugs Market Restraints

10 Global Market Forecast

• 10.1 Lifestyle Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Lifestyle Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Lifestyle Drugs by Type (2022-2027)
• 10.2 Lifestyle Drugs Market Estimates and Projections by Sales Channel
  • 10.2.1 Global Forecasted Sales of Lifestyle Drugs by Sales Channel (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Lifestyle Drugs by Sales Channel (2022-2027)
• 10.3 Lifestyle Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Lifestyle Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Lifestyle Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List